TFPI and COVID-19: On focusing on prothrombotic mechanisms, we noted COVID-19 patients in the ICU had higher coagulation factor III (CFIII; Figure 6A) and tissue factor pathway inhibitor (TFPI; Figure 6B) supporting a prothrombotic state compared to controls.